In breast cancer, EGF (epidermal growth factor) stimulation activates CDK5 to phosphorylate Girdin (Gα-interacting vesicle associated protein) at Ser1674, which activates the downstream G-coupled receptor-dependent signaling pathway for promoting cell migration [62] (Fig. 3b). Here, EGF is linked to breast cancer.